Columbia Care Introduces New Line of Formulated Cannabis Tablets

If you’ve been waiting for your inspiration to come in a pill, Columbia Care (CSE: CCHW) (OTCQX: CCHWF), one of the nation’s top MSO providers of medical cannabis and ranked #6 among the Global Cannabis 50, has launched new cannabis tablets under its PRESS brand.

Three new PRESS 2.0 hard-pressed tablets – Shine, Rally and Doze – are now available across Delaware, Massachusetts, New Jersey, Virginia and West Virginia, with launches in additional states planned. The company says PRESS 2.0 was created as a portable, convenient cannabis consumption option.

“A growing number of patients and customers are looking for a discreet and reliable way to consume cannabis – which is exactly what our PRESS brand offers,” said BJ Carretta, SVP of Brands, Columbia Care. “PRESS 2.0 goes a step further by offering patients and customers the opportunity to explore three consciously crafted formulations with a range of THC to CBD, or THC to CBG ratios, plus functional ingredients.”

All three new products feature fast-acting cannabis and special formulations designed for morning, afternoon, and night routines: Shine tablets include CBG, green tea extract, turmeric and vitamin C to fine tune your morning; Rally tablets are made with CBG, turmeric and vitamin B12 for the afternoon slump; and the Doze tablets feature CBD and magnesium to wind down your day.

For more information about PRESS and PRESS 2.0, visit www.presstablets.com